PRKDC and cancer: In some cancer cells, aldolase can promote DNA-dependent protein kinase (DNA-PK) activation by binding to its catalytic subunit; DNA-PK phosphorylates the tumor suppressor protein p53 to enhance its activity (Ma et al., 2018).